Literature DB >> 7115748

Purification of canine post-heparin hepatic lipase.

P H Frost, V G Shore, R J Havel.   

Abstract

A method for the purification of canine hepatic lipase from post-heparin hepatic venous blood plasma was developed and found applicable to mixed venous post-heparin plasma. The method employs sequential (NH4)2SO4 fractionation, heparin-Sepharose chromatography at pH 8.8 and, finally, adsorption to antiserum prepared against dog pre-heparin plasma. The lipase was purified 10,000-fold. The specific activity assayed with Intralipid as substrate was 840 mumol free fatty acid h-1 . mg-1. Enzyme recovery was 20%. Upon electrophoresis of the purified lipase in polyacrylamide gel containing SDS, a major protein-staining band with an apparent molecular weight of 60,000 was consistently found. This component accounted for 85-90% of the protein applied to the gel, and by amino acid analysis appeared to be distinct from canine antithrombin III, a protein thought to contaminate hepatic lipase purified by earlier methods.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7115748     DOI: 10.1016/0005-2760(82)90086-8

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  3 in total

1.  An apolipoprotein A-V gene SNP is associated with marked hypertriglyceridemia among Asian-American patients.

Authors:  Clive R Pullinger; Bradley E Aouizerat; Irina Movsesyan; Vincent Durlach; Eric J Sijbrands; Katsuyuki Nakajima; Annie Poon; Geesje M Dallinga-Thie; Hiroaki Hattori; Lauri L Green; Pui-Yan Kwok; Richard J Havel; Philip H Frost; Mary J Malloy; John P Kane
Journal:  J Lipid Res       Date:  2008-04-25       Impact factor: 5.922

2.  Atypical familial dysbetalipoproteinemia associated with apolipoprotein phenotype E3/3.

Authors:  R J Havel; L Kotite; J P Kane; P Tun; T Bersot
Journal:  J Clin Invest       Date:  1983-07       Impact factor: 14.808

3.  A non-circulating pool of factor XI associated with glycosaminoglycans in mice.

Authors:  Bassem M Mohammed; Qiufang Cheng; Anton Matafonov; Ingrid M Verhamme; Jonas Emsley; Keith R McCrae; Owen J T McCarty; Andras Gruber; David Gailani
Journal:  J Thromb Haemost       Date:  2019-06-17       Impact factor: 16.036

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.